[ 5/9 (수) ]
KPAC 2018 (Korea Pharma Associations Conference/한국제약산업공동컨퍼런스)



담당자 정보 임현희, +82-2-6263-2058, hyunhee.leem@mci-group.kr
* 본 세션은 무료 세션으로 BIO KOREA 2018을 등록하신 분들은 모두 참가 가능하십니다.
시간 주제
12 : 00 ~ 13 : 30 Policy luncheon RTM (Invitation Only)
13 : 30 ~ 14 : 10 Opening Remarks
14 : 10 ~ 14 : 25 Congratulatory Remarks
14 : 25 ~ 14 : 30 Photo Time
14 : 30 ~ 15 : 10 Keynote Speech (MNC : Cutting edge in new drug R&D with open innovation)
Philip Tagari, VP of Research, AMGEN
패널토론
15 : 10 ~ 16 : 20 Session 1: Future of Oncology Biomarkers and How Open Innovation Works
Rosa Hee Jung Kim, Senior Manager, AstraZeneca
Hunwoo Shin, Director, BD&L, MSD
Byoung Chul Cho, Severance Hospital
16 : 40 ~ 17 : 50 Session 2: Implement 'Quick win fast fail strategy' for new drug R&D
Takao Honda, Sr. Manager, External Innovation, Eli Lilly Japan
Su Jin Ahn, Director, Yuhan
Hyun Ju Yang, Executive Director), Daiichi Sankyo Korea